Yimaitong strategically joins hands with NCCN to bring the latest NCCN oncology guidelines to Chinese doctors

Beijing time on June 15, 2022, Medical Mail (02192.HK) and the National Comprehensive Cancer Network (NCCN) strategic cooperation conference was held in the form of network connection. This is the first time that NCCN, an authoritative oncology institution, has cooperated with the Chinese Internet doctor platform.

Through this cooperation, both parties will give full play to their respective advantages and work together to provide Chinese clinical oncologists with high-quality, high-value, The patient-centered tumor diagnosis and treatment plan will further help Chinese doctors to make the best clinical decisions, and ultimately help domestic tumor patients to live longer and better.

>About NCCN – National Comprehensive Cancer Network (NCCN):The world’s top academic organization in the field of oncology, consisting of 32 top cancer centers in the United States, Its guidelines cover approximately 97% of cancer patients worldwide.

About Yimaitong – Yimaitong (02192.HK): With the dual background of medical care and the Internet, we continue to provide high-quality services for medical professionals. The entire platform has about 5.5 million users, of which about 3.1 million are practicing doctors, covering about 75% of Chinese practicing doctors. It is currently the largest online professional doctor platform in China.

Dr Carl Introduced the mission of NCCN and the goals of cooperation between the two parties:

“NCCN is delighted to cooperate with this outstanding organization, iMaiTong, to ensure NCCN Content can be reliably accessed and updated. It is exciting to see the success of this international collaboration thanks to the strong leadership of both organizations. This multi-year collaboration aims to positively impact the diagnosis and treatment of cancer patients in China Both parties will work together to promote high-quality cancer diagnosis and treatment in China and around the world.”

Dr. Indicates:

“This new cooperation enables NCCN resources to be available on both the NCCN China website and the Yimaitong website at the same time. Chinese patients and physicians can obtain accurate and licensed NCCN content for free on the Yimaitong platform.In order to make non-English The counterparts in the country can continue to obtain the NCCN guidelines, NCCN attaches great importance to the translation of the guidelines, and looks forward to completing the new Chinese version translation through the cooperation between NCCN and Yimaitong.”

President and Executive Director of Yi Mai Tong Technology Co., Ltd. Tian Lixin introduced the concept of Yi Mai Tong:

“Yimaitong has been adhering to ‘sensing the pulse of medicine in the world and helping China’s clinical decision-making’ for many years” as the orientation, with the medical information capability as the core, and make every effort to provide information technology support and clinical information decision-making reference for the clinical and scientific research work of Chinese doctors. ”

Through this cooperation with NCCN, Yimaitong will provide Chinese clinicians with the most cutting-edge, timely and accurate decision-making reference information, so that patients can enjoy the latest It is an “international plan” for the diagnosis and treatment of tumors.

Meanwhile, Yimaitong takes disease as a unit, adheres to the principle of “evidence-based, comprehensive, timely and mutual assistance”, and focuses on medical interdisciplinary , to build the Yizhiyuan knowledge base platform, which serves as a powerful supplement to the Yimaitong clinical guidelines in the process of doctors’ clinical decision-making.

Xin Jiangtao, Vice President of Yimaitong Technology Co., Ltd., introduced how to use the NCCN China website and how to easily access the website of Yimaitong The clinical guideline APP and website download the NCCN guideline and introduce the guideline in translation:

“The first phase of Translations include B-cell lymphoma, hepatobiliary cancer, colon cancer, non-small cell lung cancer, breast cancer, gastric cancer, acute lymphoblastic leukemia, head and neck tumors, and more. In the future, Chinese doctors will provide Chinese guidelines for more tumor types. “

Xin Jiangtao also sent an invitation to the online audience, hoping that everyone will actively sign up to participate in the translation and revision of the Chinese version of the NCCN Guidelines, in order to further improve the accuracy of the Chinese version of the guidelines, Timeliness and legibility make a contribution.

As of press time, all 83 NCCN subsidiaries The latest clinical practice guidelines of the Ministry of Health have been launched on the Yimaitong clinical guidelines. Doctors in the field of oncology can access the Yimaitong website/mobile terminal (the Yimaitong APP, clinical guideline APP)freefree strong>Download and learn the latestGenuine NCCN Guidelines.< /p>

In addition, with the continuous approval of new drugs in the field of oncology, the continuous advancement of drug research, and the efficient iteration of NCCN guidelines, Yimaitong will also be updated closely , to provide Chinese doctors with the latest guidelines as soon as possible.

It is expected that from the end of June, Yimaitong will be launched on NCCN in succession The Chinese translation version of the guideline is available for Chinese doctors to learn and use.Users can download it on the Yimaitong clinical guideline platform.

< p>In addition to reaching a strategic cooperation with NCCN, in the past week, iMaiTong also issued an announcement announcing the acquisition of a medical planning company-Beijing Focus Innovation Technology Co., Ltd. Company, the company has planned and publicized the well-known “Guidelines for Rational Drug Use in Cardiovascular Diseases” in the industry. Yimaitong’s continuous expansion of new partners in the field of guidelines is precisely in accordance with “Sensing the pulse of medicine in the world, helping China’s clinical decision-making” to practice the core values. p>

Through the compilation, implementation and publicity activities of a series of clinical guidelines, the standardization of doctors’ clinical treatment behavior can be improved, and the clinical outcomes of patients can be improved. Through the cooperation with guideline development agencies and guideline planning agencies, the quality of medical information services of Yimaitong will be further improved. Yimaitong will deliver more latest clinical guidelines to users in a timely manner, and cover more sub-specialty areas, so as to better To help doctors make the best clinical decisions. On the other hand, Yi Mai Tong Association is committed to the publicity and implementation of the guidelines to the general public group of primary physicians. The grassroots doctors are responsible for the diagnosis, treatment and long-term follow-up management of most patients in China. However, unlike the good training system in large hospitals, grass-roots doctors are more self-exploration in clinical practice, and many grass-roots doctors have a low clinical level. The clinical guidelines give grass-roots doctors a shortcut to gain valuable clinical experience from authoritative experts, help standardize doctors’ diagnosis and treatment behavior, narrow the differences in diagnosis and treatment levels between different medical institutions and clinicians, and are of great significance for reducing the cost of medical treatment for patients and improving the quality of medical care. . Yimaitong hopes to take on more social responsibilities, truly promote these guidelines and consensus to the majority of grassroots doctors, and contribute to the improvement of China’s overall medical level.

About Yimaitong Clinical Guidelines span>Yimaitong is the earliest platform in China to set foot in the guide market, and has obtained NCCN Guidelines, Chinese Medical Association Guidelines, Wanfang Medicine Guidelines and other well-known institutions. At present, the clinical guide channel of Yimaitong brings together the latest domestic and foreign clinical guidelines and expert consensus and recommendations, and provides online reading and downloading of the latest domestic and foreign clinical guidelines interpretation, guide translation, Chinese guide, etc., which is the largest genuine clinical guide in China. Guide library. At the same time, Yimaitong is continuing to develop more guideline fields and develop cooperation with more professional guideline-making institutions.

Open Yimaitong/Clinical Guidelines AppAfter registration/login span>Search “NCCN” to view the latest online genuine NCCN guidelines

Click“read the original text”, download the clinical guideline app, and know the world’s clinical guidelines without leaving home